Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort.

Shahabi P, Lamothe F, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Asselin G, Mongrain I, Valois D, Gaulin Marion MJ, Lemieux Perreault LP, Perreault S, Dubé MP.

Pharmacogenomics J. 2019 Apr;19(2):147-156. doi: 10.1038/s41397-017-0005-1. Epub 2018 Jan 3.

2.

Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection.

Aguirre S, Luthra P, Sanchez-Aparicio MT, Maestre AM, Patel J, Lamothe F, Fredericks AC, Tripathi S, Zhu T, Pintado-Silva J, Webb LG, Bernal-Rubio D, Solovyov A, Greenbaum B, Simon V, Basler CF, Mulder LC, García-Sastre A, Fernandez-Sesma A.

Nat Microbiol. 2017 Mar 27;2:17037. doi: 10.1038/nmicrobiol.2017.37.

PMID:
28346446
3.

Cloacibacillus sp., a Potential Human Pathogen Associated with Bacteremia in Quebec and New Brunswick.

Domingo MC, Yansouni C, Gaudreau C, Lamothe F, Lévesque S, Tremblay C, Garceau R.

J Clin Microbiol. 2015 Oct;53(10):3380-3. doi: 10.1128/JCM.01137-15. Epub 2015 Jul 29.

4.

Predictors of asymptomatic Clostridium difficile colonization on hospital admission.

Kong LY, Dendukuri N, Schiller I, Bourgault AM, Brassard P, Poirier L, Lamothe F, Béliveau C, Michaud S, Turgeon N, Toye B, Frost EH, Gilca R, Dascal A, Loo VG.

Am J Infect Control. 2015 Mar 1;43(3):248-53. doi: 10.1016/j.ajic.2014.11.024.

PMID:
25728150
5.

Host and pathogen factors for Clostridium difficile infection and colonization.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.

N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.

6.

Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.

Bruneau J, Daniel M, Abrahamowicz M, Zang G, Lamothe F, Vincelette J.

Am J Epidemiol. 2011 May 1;173(9):1049-58. doi: 10.1093/aje/kwq479. Epub 2011 Mar 1.

7.

In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Bourgault AM, Lamothe F, Loo VG, Poirier L; CDAD-CSI Study Group.

Antimicrob Agents Chemother. 2006 Oct;50(10):3473-5.

8.

A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials.

Boileau C, Bruneau J, Al-Nachawati H, Lamothe F, Vincelette J.

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):489-95.

PMID:
16010174
9.

Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.

Makedonas G, Bruneau J, Alary M, Tsoukas CM, Lowndes CM, Lamothe F, Bernard NF.

AIDS. 2005 Feb 18;19(3):251-9.

PMID:
15718835
10.
11.

Appropriateness of extending the intensive phase of treatment based on smear results.

Enarson DA, Jindani A, Kuaban C, Lamothe F, Louissaint M, Ottmani SE, Ramarokoto H, Ridderhof JC, Urbanczik R.

Int J Tuberc Lung Dis. 2004 Jan;8(1):114-6. No abstract available.

PMID:
14974754
12.

Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs.

Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.

AIDS Care. 2003 Apr;15(2):187-95.

PMID:
12856340
13.

HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity.

Makedonas G, Bruneau J, Lin H, Sékaly RP, Lamothe F, Bernard NF.

AIDS. 2002 Aug 16;16(12):1595-602.

PMID:
12172080
14.

HIV-positive notification and behavior changes in Montreal injection drug users.

Brogly SB, Bruneau J, Lamothe F, Vincelette J, Franco EL.

AIDS Educ Prev. 2002 Feb;14(1):17-28.

PMID:
11900107
15.

Should all stool specimens be routinely tested for Clostridium difficile?

Bourgault AM, Yechouron A, Gaudreau C, Gilbert H, Lamothe F.

Clin Microbiol Infect. 1999 Apr;5(4):219-223.

16.

Sex-specific determinants of HIV infection among injection drug users in Montreal.

Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J, Vassal A, Franco EL.

CMAJ. 2001 Mar 20;164(6):767-73.

17.

Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Jetté LP, Delage G, Ringuette L, Allard R, De Wals P, Lamothe F, Loo V; Pneumococcus Study Group.

J Clin Microbiol. 2001 Feb;39(2):733-7.

18.

Risk behaviour change and HIV infection among injection drug users in Montreal.

Brogly SB, Bruneau J, Vincelette J, Lamothe F, Franco EL.

AIDS. 2000 Nov 10;14(16):2575-82.

PMID:
11101070
19.

Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.

Labbé AC, Bourgault AM, Vincelette J, Turgeon PL, Lamothe F.

Antimicrob Agents Chemother. 1999 Oct;43(10):2517-9.

20.

High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.

Bruneau J, Lamothe F, Franco E, Lachance N, Désy M, Soto J, Vincelette J.

Am J Epidemiol. 1997 Dec 15;146(12):994-1002.

PMID:
9420522
21.

Update on Pan-American activities in the field of anaerobes: Canada.

Bourgault AM, Lamothe F.

Clin Infect Dis. 1997 Sep;25 Suppl 2:S237-40. Review.

PMID:
9310691
22.

Fusobacterium bacteremia: clinical experience with 40 cases.

Bourgault AM, Lamothe F, Dolcé P, Saint-Jean L, Saint-Antoine P.

Clin Infect Dis. 1997 Sep;25 Suppl 2:S181-3. No abstract available.

PMID:
9310671
23.

Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections.

Dalmau D, Cayouette M, Lamothe F, Vincelette J, Lachance N, Bourgault AM, Gaudreau C, Turgeon PL.

Clin Infect Dis. 1997 May;24(5):874-7.

PMID:
9142785
24.

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease.

Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, Fenoll A, Hortal M, Jetté LP, Jorgensen JH, Lamothe F, Latorre C, Macfarlane JT, Shlaes DM, Smart LE, Taunay A.

Clin Infect Dis. 1996 Jun;22(6):973-81.

PMID:
8783696
25.

Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.

Lamothe F, D'Amico P, Ghosn P, Tremblay C, Braidy J, Patenaude JV.

Clin Infect Dis. 1995 Dec;21(6):1469-70.

PMID:
8749635
26.

Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.

Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, Trepo C, Warter A.

Am J Trop Med Hyg. 1995 Apr;52(4):293-6.

PMID:
7537942
27.

[Can bilharziasis be considered a health priority in western Africa, justifying control programs of large scope?].

Sellin B, Rey JL, Mouchet F, Lamothe F, Develoux M.

Med Trop (Mars). 1995;55(1):11-6. Review. French. No abstract available.

PMID:
7637601
28.

Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Turgeon P, Turgeon V, Gourdeau M, Dubois J, Lamothe F.

Antimicrob Agents Chemother. 1994 Oct;38(10):2276-9.

29.

Illicit use of methadone among i.v. drug users in Montreal.

Lauzon P, Vincelette J, Bruneau J, Lamothe F, Lachance N, Brabant M, Soto J.

J Subst Abuse Treat. 1994 Sep-Oct;11(5):457-61.

PMID:
7869467
30.

Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.

Lamothe F, Bruneau J, Coates R, Rankin JG, Soto J, Arshinoff R, Brabant M, Vincelette J, Fauvel M.

CMAJ. 1993 Oct 1;149(7):945-51.

31.

Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Lachance N, Gaudreau C, Lamothe F, Turgeon F.

Antimicrob Agents Chemother. 1993 May;37(5):1174-6.

32.

Progression of prevalence of HIV-1 infection among injection drug users in Montreal, Quebec.

Lamothe F, Bruneau J, Soto J, Vincelette J, Brabant M, Lachance N, Fauvel M.

Can Commun Dis Rep. 1992 Jul 17;18(13):98-101. English, French. No abstract available.

PMID:
1364884
33.

Transmission of HIV-1 from seronegative but PCR-positive blood donor.

Coutlée F, Delage G, Lamothe F, Cassol S, Décary F.

Lancet. 1992 Jul 4;340(8810):59. No abstract available.

PMID:
1351642
34.

[Pneumococcal vaccine and the independently living elderly].

Lamothe F, Vincelette J.

Union Med Can. 1992 May-Jun;121(3):157. French. No abstract available.

PMID:
1615562
35.

Campylobacter upsaliensis isolated from a breast abscess.

Gaudreau C, Lamothe F.

J Clin Microbiol. 1992 May;30(5):1354-6.

36.

Survey of Bacteroides fragilis group susceptibility patterns in Canada.

Bourgault AM, Lamothe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H.

Antimicrob Agents Chemother. 1992 Feb;36(2):343-7.

37.

Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989.

Coates RA, Rankin JG, Lamothe F, Arshinoff R, Raboud J, Millson ME, Halliday ML, Bruneau J, Soto J, Vincelette J, et al.

Can J Public Health. 1992 Jan-Feb;83(1):38-41.

PMID:
1315204
38.

Thiamine deficiency and Wernicke's encephalopathy in AIDS.

Butterworth RF, Gaudreau C, Vincelette J, Bourgault AM, Lamothe F, Nutini AM.

Metab Brain Dis. 1991 Dec;6(4):207-12.

PMID:
1812394
39.

Human hydatidosis in Niger.

Develoux M, Audoin J, Lamothe F, Gali A, Warter A.

J Trop Med Hyg. 1991 Dec;94(6):423-4.

PMID:
1758016
40.

Thiamine deficiency in AIDS.

Butterworth RF, Gaudreau C, Vincelette J, Bourgault AM, Lamothe F, Nutini AM.

Lancet. 1991 Oct 26;338(8774):1086. No abstract available.

PMID:
1681392
41.

Usefulness of semi-quantitative cultures in the diagnosis of Clostridium difficile associated disease.

Poirier L, Lamothe F, Vincelette J, Bourgault AM.

Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):770-2.

PMID:
1810735
42.

Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.

Lachance N, Gaudreau C, Lamothe F, Larivière LA.

Antimicrob Agents Chemother. 1991 May;35(5):813-8.

43.

[Neurologic diseases in Niger].

Cenac A, Tout A, Audoin J, Lamothe F, Buguet A, Develoux M, Gaultier Y.

Med Trop (Mars). 1991 Apr-Jun;51(2):169-72. French.

PMID:
1895915
44.

Risk factors for HIV seropositivity among people consulting for HIV antibody testing.

Lamothe F, Bruneau J, Soto J, Brabant M, Vincelette J, Fauvel M.

CMAJ. 1990 Nov 1;143(9):828-9. No abstract available. Erratum in: Can Med Assoc J 1990 Dec 15;143(12):1291.

45.
46.

[The antipneumococcal vaccine and elderly persons: not a luxury, a necessity].

Lamothe F, Vincelette J.

Union Med Can. 1990 Jan-Feb;119(1):39-40. French. No abstract available.

PMID:
2316062
47.

[Value of echography in the study of periportal fibrosis caused by schistosomiasis in an endemic African zone].

Lamothe F, Develoux M, N'Goran E, Yapi Y, Sellin B.

Ann Radiol (Paris). 1990;33(1):44-7. French.

PMID:
2163231
48.

Prevalence of vaginal schistosomiasis caused by Schistosoma haematobium in an endemic village in Niger.

Renaud G, Devidas A, Develoux M, Lamothe F, Bianchi G.

Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):797. No abstract available.

PMID:
2515636
49.

Ultrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel.

Devidas A, Lamothe F, Develoux M, Mouchet F, Sellin B.

Ann Soc Belg Med Trop. 1989 Mar;69(1):57-65.

PMID:
2499278

Supplemental Content

Loading ...
Support Center